Press release
Pharmacogenomics Market to Grow at 9.3% During 2022-2027, Supported by Development of Precision Medicine
Pharmacogenomics Market
Pharmacogenomics represents the study of inherited variations in human genes in response to specific drugs. It utilizes the principles of pharmacology and genomics to develop effective and safe medications customized to an individual's genetic makeup. This involves the use of several technologies, including polymerase chain reaction (PCR), microarray, deoxyribonucleic acid (DNA) sequencing, mass spectrometry, etc. The genetic tests performed aid in determining a patient's susceptibility to certain diseases and the efficacy of the newly developed drugs. Consequently, pharmacogenomics finds extensive applications in the treatment of various diseases and disorders, such as cardiovascular, Alzheimer's, cancer, acquired immunodeficiency syndrome (AIDS), etc.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/pharmacogenomics-market/requestsample
Global Pharmacogenomics Market Growth:
The expanding pharmaceutical industry is one of the key factors driving the global pharmacogenomics market. Moreover, the rising requirement for precision medicines with enhanced drug safety is further bolstering the market growth. Besides this, the growing adoption of targeted drug therapies with minimal side effects and improved efficacy owing to the escalating prevalence of chronic lifestyle diseases, is also propelling the product demand. In line with this, pharmacogenomics is increasingly being utilized for cancer treatments and anticipating the possible drug responses, resistance, efficacy, toxicity, etc., of the chemotherapeutic and targeted immune biologic agents. Furthermore, numerous technological advancements, including the development of pharmacogenomic biomarker labeling solutions, are expected to fuel the pharmacogenomics market over the forecasted period.
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/pharmacogenomics-market
Key Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the industry has also been examined along with the profiles of the key players being:
• Abbott Laboratories
• AstraZeneca plc
• Bayer AG
• Becton Dickinson and Company
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Illumina Inc.
• Johnson & Johnson
• Merck KGaA
• Myriad Genetics Inc
• Qiagen N.V.
• Thermo Fisher Scientific Inc
Breakup by Technology:
• Polymerase Chain Reaction
• Microarray
• DNA Sequencing
• Mass Spectrometry
• Electrophoresis
• Others
Breakup by Application:
• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Neurological Diseases
• Psychiatry
• Pain Management
• Others
Breakup by End User:
• Hospitals and Clinics
• Academic and Research Institutes
Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Other Reports of IMARC Group:
• https://www.imarcgroup.com/ossein-gelatine-technical-material-market-report
• https://www.imarcgroup.com/membrane-bioreactor-market
• https://www.imarcgroup.com/e-cigarette-market
• https://www.imarcgroup.com/b2c-e-commerce-market
• https://www.imarcgroup.com/legal-process-outsourcing-market
• https://www.imarcgroup.com/oxidized-polyethylene-wax-market
• https://www.imarcgroup.com/teeth-whitening-products-market
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market to Grow at 9.3% During 2022-2027, Supported by Development of Precision Medicine here
News-ID: 2845784 • Views: …
More Releases from IMARC Group
Hydrogen Fluoride Manufacturing Plant DPR 2026: Investment Cost, Market Growth & …
Setting up a hydrogen fluoride manufacturing plant positions investors within a strategically important segment of the global specialty chemicals and fluorochemicals industry, driven by increasing demand for semiconductor manufacturing, refrigerant production, and pharmaceutical intermediates. As modern industrial processes advance, electronics manufacturing expands, and the need for high-purity fluorine compounds grows, hydrogen fluoride continues to gain traction across semiconductor fabrication, aluminum production, and petroleum refining worldwide. Rising demand from high-tech industries,…
Vinyl Acetate Ethylene Production Plant Cost 2026: Industry Overview and Profita …
Setting up a Vinyl Acetate Ethylene Production Plant positions investors in one of the most stable and essential segments of the specialty chemicals and polymer value chain, backed by sustained global growth driven by growing construction activity, rising demand for high-performance dry-mix mortars, increasing use in paints and coatings, and the dual-benefit advantages of delivering flexible, low-VOC polymer binder solutions that meet both industrial performance standards and evolving environmental compliance…
Fluff Pulp Manufacturing Plant DPR & Unit Setup - 2026: Machinery Cost, CapEx/Op …
Setting up a fluff pulp manufacturing plant positions investors within a strategically important segment of the global hygiene products and absorbent materials industry, driven by increasing demand for disposable hygiene products, absorbent personal care items, and medical applications. As consumer hygiene standards advance, disposable product adoption expands, and the need for high-quality absorbent materials grows, fluff pulp continues to gain traction across baby diapers, adult incontinence products, feminine hygiene items,…
Fire Alarms Manufacturing Plant DPR & Unit Setup - 2026: Demand Analysis and Pro …
Setting up a fire alarms manufacturing plant positions investors within a strategically important segment of the global safety and security equipment industry, driven by increasing demand for fire detection and safety systems, stringent building safety regulations, and growing awareness of fire protection measures. As modern construction practices advance, smart building integration expands, and the need for advanced fire safety infrastructure grows, fire alarms continue to gain traction across commercial buildings,…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
